ARTICLE | Company News
TapImmune, Aeras deal
February 8, 2010 8:00 AM UTC
The parties signed a letter of intent for the foundation to evaluate the efficacy of TapImmune's transporter associated with antigen processing (TAP) technology for use as an adjuvant with the founda...